Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (600436 CH)
Watchlist
93
Analysis
Health Care
•
China
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. manufactures and markets Chinese traditional medicines, including Pientzehuang, Pientzehuang capsules, Pientzehuang lozenge, cough syrup, and other related products.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.
•
12 May 2024 16:12
China Healthcare Weekly (May12)-Policy Catalyst in Medical Device, GLP-1 Overvaluation, Pientzehuang
New policy catalysts in medical device sector arrives.Current valuation of weight-loss drug companies have “big bubble”.Due to China's de...
Xinyao (Criss) Wang
Follow
351 Views
Share
bearish
•
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.
•
31 Jan 2024 08:55
Zhangzhou Pientzehuang Pharmaceutical (600436.CH) 2023 Results - Get Ready for More Downside Ahead
China's de-financialization process would change the investment logic of companies/products with strong financial attributes.Their growth potential...
Xinyao (Criss) Wang
Follow
304 Views
Share
bullish
•
Seres Group
•
01 Dec 2024 15:28
Quiddity SSE50/180 Dec 24 Results: All SSE 50 ADDs in the LONGs Basket; Positive Start; More to Come
All five SSE 50 ADDs are in our previous LONGs basket. Since 5th Nov, the LONGs have outperformed the index by 2.7% which was a better return than...
Janaghan Jeyakumar, CFA
Follow
339 Views
Share
bullish
•
Seres Group
•
01 Dec 2024 09:30
SSE50/SSE180 Index Rebalance: Couple of Surprises; Seres Group's Multiple Inclusions; US$3.2bn Trade
5/18 changes for the SSE50/180 in Dec. Seres Group is an add to both indices and the CSI300, so plenty to buy there. Couple of other surprises. The...
Brian Freitas
Follow
507 Views
Share
bullish
•
Seres Group
•
04 Nov 2024 18:30
Quiddity Leaderboard SSE50/180 Dec 24: Multiple Changes to Expectations; ~US$2.3bn Collective Flows
We estimate SSE 50 one-way flow to be US$1.98bn and SSE 180 one-way flow to be US$286mn during the December 2024 index rebal event.
Janaghan Jeyakumar, CFA
Follow
388 Views
Share
1
2
3
4
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3
x